Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
August 08 2023 - 4:01PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE
13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of August 2023
Commission File Number 001-37381
MEDIGUS LTD.
(Translation of registrant’s name into English)
10 HaNechoshet Street Tel-Aviv, 6971072, Israel
(Address of principal executive
offices)
Indicate by check mark whether the registrant files
or will file annual reports under cover Form 20-F or Form 40-F.
Form 20-F ☒
Form 40-F ☐
EXPLANATORY NOTE
Medigus Ltd. (the “Company”),
hereby announces that the shareholders of the Company approved all the proposals brought before the annual general meeting of shareholders
scheduled for August 7, 2023 and adjourned to August 8, 2023 (the “Meeting”),
as originally proposed and included in the Company’s proxy statement for the Meeting, that was attached as Exhibit 99.1 to
a Report of Foreign Private Issuer on Form 6-K that the Company furnished to the Securities and Exchange Commission on June 30, 2023.
25,694,490 ordinary shares, representing
approximately 9.94% of the Company’s issued and outstanding ordinary shares as of the record date, were present or represented by
proxy at the Meeting.
This Form 6-K is incorporated
by reference into the Company’s Registration Statements on Form S-8 (File Nos. 333-258624, 333-206803,
333-221019
and 333-229429).
SIGNATURE
Pursuant to the requirements of
the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto
duly authorized.
|
MEDIGUS LTD. |
|
|
|
Date: August 8, 2023 |
By: |
/s/ Tali Dinar |
|
|
Tali Dinar |
|
|
Chief Financial Officer |
Medigus (NASDAQ:MDGS)
Historical Stock Chart
From Aug 2024 to Sep 2024
Medigus (NASDAQ:MDGS)
Historical Stock Chart
From Sep 2023 to Sep 2024